Recent advances and prospects in the isolation by size of epithelial tumor cells (ISET) methodology

Technology in Cancer Research and Treatment

Volumn 12, Issue 4, 2013, Pages 295-309

  Ma, Yu Chao ^a   Wang, Li ^a   Yu, Feng Lei ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Circulating tumor cells; Circulating tumor microemboli; Epithelial mesenchymal transition; Isolation by size of epithelial tumor cells

Indexed keywords

CYTOKERATIN; EPITHELIAL CELL ADHESION MOLECULE; NERVE CELL ADHESION MOLECULE; TUMOR MARKER; UVOMORULIN; VIMENTIN;

ANTIBODY LABELING; ARTICLE; BLOOD SAMPLING; CELL STRUCTURE; CHEMOTHERAPY; CIRCULATING TUMOR CELL; CIRCULATING TUMOR MICROEMBOLI; CLINICAL PRACTICE; CLINICAL RESEARCH; CONTROLLED CLINICAL TRIAL (TOPIC); CYTODIAGNOSIS; CYTOPATHOLOGY; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM TUMOR; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ANALYSIS; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOTOXICITY; ISOLATION BY SIZE OF EPITHELIAL TUMOR CELL; ISOLATION PROCEDURE; METHODOLOGY; NONHUMAN; RADIOTHERAPY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR XENOGRAFT; ANIMAL; CELL SEPARATION; CELL SIZE; NEOPLASM; PATHOLOGY; PRENATAL DIAGNOSIS; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; TUMOR EMBOLISM;

ANIMALS; CELL SEPARATION; CELL SIZE; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; NEOPLASMS, GLANDULAR AND EPITHELIAL; NEOPLASTIC CELLS, CIRCULATING; PRENATAL DIAGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84880064826     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.7785/tcrt.2012.500328     Document Type: Article

References (83)

1. World Health Organization. The Global Burden of Disease: 2004 Update. (World Health Organization, 2008).
2. Kohn, E. C., Liotta, L. A. Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Research 55, 1856-1862 (1995). DOI
3. Fidler, I. J. Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Research 38, 2651-2660 (1978). DOI
4. Gupta, G. P., Massague, J. Cancer metastasis: building a framework. Cell 127, 679-695 (2006). DOI: 10.1016/j.cell.2006.11.001
5. Mostert, B., Sleijfer, S., Foekens, J. A., Gratama, J. W. Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer. Cancer Treatment Reviews 35, 463-474 (2009). DOI: 10.1016/j.ctrv.2009.03.004
6. Ross, A. A., Cooper, B. W., Lazarus, H. M., Mackay, W., Moss, T. J., Ciobanu, N., Tallman, M. S., Kennedy, M. J., Davidson, N. E., Sweet, D., et al. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 82, 2605-2610 (1993). DOI
7. Vona, G., Sabile, A., Louha, M., Sitruk, V., Romana, S., Schutze, K., Capron, F., Franco, D., Pazzagli, M., Vekemans, M., Lacour, B., Brechot, C., Paterlini-Brechot, P. Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulatingtumor cells. The American Journal of Pathology 156, 57-63 (2000). DOI: 10.1016/S0002-9440(10)64706-2
8. Meng, S., Tripathy, D., Frenkel, E. P., Shete, S., Naftalis, E. Z., Huth, J. F., Beitsch, P. D., Leitch, M., Hoover, S., Euhus, D., Haley, B., Morrison, L., Fleming, T. P., Herlyn, D., Terstappen, L. W., Fehm, T., Tucker, T. F., Lane, N., Wang, J., Uhr, J. W. Circulating tumor cells in patients with breast cancer dormancy. Clinical Cancer Research: an Official Journal of the American Association for Cancer Research 10, 8152-8162 (2004). DOI: 10.1158/1078-0432.CCR-04-1110
9. Zabaglo, L., Ormerod, M. G., Parton, M., Ring, A., Smith, I. E., Dowsett, M. Cell filtration-laser scanning cytometry for the characterisation of circulating breast cancer cells. Cytometry. Part A: the Journal of the International Society for Analytical Cytology 55, 102-108 (2003). DOI: 10.1002/cyto.a.10071
10. Paterlini-Brechot, P., Benali, N. L. Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Letters 253, 180-204 (2007). DOI: 10.1016/j.canlet.2006.12.014
11. Woywodt, A., Goldberg, C., Scheer, J., Regelsberger, H., Haller, H., Haubitz, M. An improved assay for enumeration of circulating endothelial cells. Annals of Hematology 83, 491-494 (2004). DOI: 10.1007/s00277-004-0878-3
12. Hofman, V., Bonnetaud, C., Ilie, M. I., Vielh, P., Vignaud, J. M., Flejou, J. F., Lantuejoul, S., Piaton, E., Mourad, N., Butori, C., Selva, E., Poudenx, M., Sibon, S., Kelhef, S., Venissac, N., Jais, J. P., Mouroux, J., Molina, T. J., Hofman, P. Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker. Clinical Cancer Research: an Official Journal of the American Association for Cancer Research 17, 827-835 (2011). DOI: 10.1158/1078-0432.CCR-10-0445
13. Hofman, V. J., Ilie, M. I., Bonnetaud, C., Selva, E., Long, E., Molina, T., Vignaud, J. M., Flejou, J. F., Lantuejoul, S., Piaton, E., Butori, C., Mourad, N., Poudenx, M., Bahadoran, P., Sibon, S., Guevara, N., Santini, J., Venissac, N., Mouroux, J., Vielh, P., Hofman, P. M. Cytopathologic detection of circulating tumor cells using the isolation by size of epithelial tumor cell method: promises and pitfalls. American Journal of Clinical Pathology 135, 146-156 (2011). DOI: 10.1309/AJCP9X8OZBEIQVVI
14. Krebs, M. G., Hou, J. M., Sloane, R., Lancashire, L., Priest, L., Nonaka, D., Ward, T. H., Backen, A., Clack, G., Hughes, A., Ranson, M., Blackhall, F. H., Dive, C. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and-independent approaches. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 7, 306-315 (2012). DOI: 10.1097/JTO.0b013e31823c5c16
15. Hristozova, T., Konschak, R., Budach, V., Tinhofer, I. A simple multicolor flow cytometry protocol for detection and molecular characterization of circulating tumor cells in epithelial cancers. Cytometry. Part A: the Journal of the International Society for Analytical Cytology (2012). DOI: 10.1002/cyto.a.22041
16. Cohen, S. J., Alpaugh, R. K., Gross, S., O'Hara, S. M., Smirnov, D. A., Terstappen, L. W., Allard, W. J., Bilbee, M., Cheng, J. D., Hoffman, J. P., Lewis, N. L., Pellegrino, A., Rogatko, A., Sigurdson, E., Wang, H., Watson, J. C., Weiner, L. M., Meropol, N. J. Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer. Clinical Colorectal Cancer 6, 125-132 (2006). DOI: 10.3816/CCC.2006.n.029
17. Strijbos, M. H., Gratama, J. W., Kraan, J., Lamers, C. H., den Bakker, M. A., Sleijfer, S. Circulating endothelial cells in oncology: pitfalls and promises. British Journal of Cancer 98, 1731-1735 (2008). DOI: 10.1038/sj.bjc.6604383
18. Smirnov, D. A., Foulk, B. W., Doyle, G. V., Connelly, M. C., Terstappen, L. W., O'Hara, S. M. Global gene expression profiling of circulating endothelial cells in patients with metastatic carcinomas. Cancer Research 66, 2918-2922 (2006). DOI: 10.1158/0008-5472.CAN-05-4003
19. Hou, J. M., Krebs, M., Ward, T., Sloane, R., Priest, L., Hughes, A., Clack, G., Ranson, M., Blackhall, F., Dive, C. Circulating tumor cells as a window on metastasis biology in lung cancer. The American Journal of Pathology 178, 989-996 (2011). DOI: 10.1016/j.ajpath.2010.12.003
20. Khoja, L., Backen, A., Sloane, R., Menasce, L., Ryder, D., Krebs, M., Board, R., Clack, G., Hughes, A., Blackhall, F., Valle, J. W., Dive, C. A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. British Journal of Cancer 106, 508-516 (2012). DOI: 10.1038/bjc.2011.545
21. Vona, G., Estepa, L., Beroud, C., Damotte, D., Capron, F., Nalpas, B., Mineur, A., Franco, D., Lacour, B., Pol, S., Brechot, C., Paterlini-Brechot, P. Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer. Hepatology 39, 792-797 (2004). DOI: 10.1002/hep.20091
22. Pinzani, P., Salvadori, B., Simi, L., Bianchi, S., Distante, V., Cataliotti, L., Pazzagli, M., Orlando, C. Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection. Human Pathology 37, 711-718 (2006). DOI: 10.1016/j.humpath.2006.01.026
23. Pantel, K., Alix-Panabieres, C., Riethdorf, S. Cancer micrometastases. Nature Reviews. Clinical Oncology 6, 339-351 (2009). DOI: 10.1038/nrclinonc.2009.44
24. Hayes, D. F., Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Miller, M. C., Matera, J., Allard, W. J., Doyle, G. V., Terstappen, L. W. Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clinical Cancer Research: an Official Journal of the American Association for Cancer Research 12, 4218-4224 (2006). DOI: 10.1158/1078-0432.CCR-05-2821
25. Bidard, F. C., Vincent-Salomon, A., Sigal-Zafrani, B., Dieras, V., Mathiot, C., Mignot, L., Thiery, J. P., Sastre-Garau, X., Pierga, J. Y. Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells. Annals of Oncology: Official Journal of the European Society for Medical Oncology / ESMO 19, 496-500 (2008). DOI: 10.1093/annonc/mdm507
26. Stott, S. L., Lee, R. J., Nagrath, S., Yu, M., Miyamoto, D. T., Ulkus, L., Inserra, E. J., Ulman, M., Springer, S., Nakamura, Z., Moore, A. L., Tsukrov, D. I., Kempner, M. E., Dahl, D. M., Wu, C. L., Iafrate, A. J., Smith, M. R., Tompkins, R. G., Sequist, L. V., Toner, M., Haber, D. A., Maheswaran, S. Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer. Science Translational Medicine 2, 25ra23 (2010). DOI: 10.1126/scitranslmed.3000403
27. Maheswaran, S., Sequist, L. V., Nagrath, S., Ulkus, L., Brannigan, B., Collura, C. V., Inserra, E., Diederichs, S., Iafrate, A. J., Bell, D. W., Digumarthy, S., Muzikansky, A., Irimia, D., Settleman, J., Tompkins, R. G., Lynch, T. J., Toner, M., Haber, D. A. Detection of mutations in EGFR in circulating lung-cancer cells. The New England Journal of Medicine 359, 366-377 (2008). DOI: 10.1056/NEJMoa0800668
28. Nagrath, S., Sequist, L. V., Maheswaran, S., Bell, D. W., Irimia, D., Ulkus, L., Smith, M. R., Kwak, E. L., Digumarthy, S., Muzikansky, A., Ryan, P., Balis, U. J., Tompkins, R. G., Haber, D. A., Toner, M. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450, 1235-1239 (2007). DOI: 10.1038/nature06385
29. Helzer, K. T., Barnes, H. E., Day, L., Harvey, J., Billings, P. R., Forsyth, A. Circulating tumor cells are transcriptionally similar to the primary tumor in a murine prostate model. Cancer Research 69, 7860-7866 (2009). DOI: 10.1158/0008-5472.CAN-09-0801
30. Vredenburgh, J. J., Silva, O., Tyer, C., DeSombre, K., Abou-Ghalia, A., Cook, M., Layfield, L., Peters, W. P., Bast, R. C., Jr. A comparison of immunohistochemistry, two-color immunofluorescence, and flow cytometry with cell sorting for the detection of micrometastatic breast cancer in the bone marrow. Journal of Hematotherapy 5, 57-62 (1996). DOI
31. Alix-Panabieres, C., Vendrell, J. P., Slijper, M., Pelle, O., Barbotte, E., Mercier, G., Jacot, W., Fabbro, M., Pantel, K. Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer. Breast Cancer Research: BCR 11, R39 (2009). DOI: 10.1186/bcr2326
32. Schwarzenbach, H., Alix-Panabieres, C., Muller, I., Letang, N., Vendrell, J. P., Rebillard, X., Pantel, K. Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 15, 1032-1038 (2009). DOI: 10.1158/1078-0432.CCR-08-1910
33. Apostolopoulos, C., Giamas, G., Stebbing, J. Clinical significance of circulating tumor cells. Biomarkers in Medicine 1, 341-342 (2007). DOI: 10.2217/17520363.1.3.341
34. Alix-Panabieres, C., Vendrell, J. P., Pelle, O., Rebillard, X., Riethdorf, S., Muller, V., Fabbro, M., Pantel, K. Detection and characterization of putative metastatic precursor cells in cancer patients. Clinical Chemistry 53, 537-539 (2007). DOI: 10.1373/clinchem.2006.079509
35. Alix-Panabieres, C., Rebillard, X., Brouillet, J. P., Barbotte, E., Iborra, F., Segui, B., Maudelonde, T., Jolivet-Reynaud, C., Vendrell, J. P. Detection of circulating prostate-specific antigen-secreting cells in prostate cancer patients. Clinical Chemistry 51, 1538-1541 (2005). DOI: 10.1373/clinchem.2005.049445
36. Pachmann, K., Camara, O., Kavallaris, A., Krauspe, S., Malarski, N., Gajda, M., Kroll, T., Jorke, C., Hammer, U., Altendorf-Hofmann, A., Rabenstein, C., Pachmann, U., Runnebaum, I., Hoffken, K. Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 26, 1208-1215 (2008). DOI: 10.1200/JCO.2007.13.6523
37. Pachmann, K., Clement, J. H., Schneider, C. P., Willen, B., Camara, O., Pachmann, U., Hoffken, K. Standardized quantification of circulating peripheral tumor cells from lung and breast cancer. Clinical Chemistry and Laboratory Medicine: CCLM / FESCC 43, 617-627 (2005). DOI: 10.1515/CCLM.2005.107
38. Lu, J., Fan, T., Zhao, Q., Zeng, W., Zaslavsky, E., Chen, J. J., Frohman, M. A., Golightly, M. G., Madajewicz, S., Chen, W. T. Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients. International Journal of Cancer. Journal International du Cancer 126, 669-683 (2010). DOI: 10.1002/ijc.24814
39. Pantel, K., Brakenhoff, R. H., Brandt, B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nature Reviews. Cancer 8, 329-340 (2008). DOI: 10.1038/nrc2375
40. Benoy, I. H., Elst, H., Philips, M., Wuyts, H., Van Dam, P., Scharpe, S., Van Marck, E., Vermeulen, P. B., Dirix, L. Y. Real-time RT-PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer. British Journal of Cancer 94, 672-680 (2006). DOI: 10.1038/sj.bjc.6602985
41. Schmitt, M., Foekens, J. A. Circulating tumor cells in blood of primary breast cancer patients assessed by a novel RT-PCR test kit and comparison with status of bone marrow-disseminated tumor cells. Breast Cancer Research: BCR 11, 109 (2009). DOI: 10.1186/bcr2405
42. De Giorgi, V., Pinzani, P., Salvianti, F., Panelos, J., Paglierani, M., Janowska, A., Grazzini, M., Wechsler, J., Orlando, C., Santucci, M., Lotti, T., Pazzagli, M., Massi, D. Application of a filtration-and isolation-by-size technique for the detection of circulating tumor cells in cutaneous melanoma. The Journal of Investigative Dermatology 130, 2440-2447 (2010). DOI: 10.1038/jid.2010.141
43. Hofman, V., Ilie, M. I., Long, E., Selva, E., Bonnetaud, C., Molina, T., Venissac, N., Mouroux, J., Vielh, P., Hofman, P. Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay and the isolation by size of epithelial tumor cell method. International Journal of Cancer. Journal International du Cancer 129, 1651-1660 (2011). DOI: 10.1002/ijc.25819
44. de Albuquerque, A., Kubisch, I., Breier, G., Stamminger, G., Fersis, N., Eichler, A., Kaul, S., Stolzel, U. Multimarker gene analysis of circulating tumor cells in pancreatic cancer patients: a feasibility study. Oncology 82, 3-10 (2012). DOI: 10.1159/000335479
45. Saloustros, E., Perraki, M., Apostolaki, S., Kallergi, G., Xyrafas, A., Kalbakis, K., Agelaki, S., Kalykaki, A., Georgoulias, V., Mavroudis, D. Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse. Breast Cancer Research: BCR 13, R60 (2011). DOI: 10.1186/bcr2897
46. De Giorgi, V., Pinzani, P., Salvianti, F., Grazzini, M., Orlando, C., Lotti, T., Pazzagli, M., Massi, D. Circulating benign nevus cells detected by ISET technique: warning for melanoma molecular diagnosis. Archives of Dermatology 146, 1120-1124 (2010). DOI: 10.1001/archdermatol.2010.264
47. Schuster, R., Bechrakis, N. E., Stroux, A., Busse, A., Schmittel, A., Thiel, E., Foerster, M. H., Keilholz, U. Prognostic relevance of circulating tumor cells in metastatic uveal melanoma. Oncology 80, 57-62 (2011). DOI: 10.1159/000328283
48. Pinzani, P., Mazzini, C., Salvianti, F., Massi, D., Grifoni, R., Paoletti, C., Ucci, F., Molinara, E., Orlando, C., Pazzagli, M., Neri, B. Tyrosinase mRNA levels in the blood of uveal melanoma patients: correlation with the number of circulating tumor cells and tumor progression. Melanoma Research 20, 303-310 (2010). DOI: 10.1097/CMR.0b013e32833906e3
49. Peck, K., Sher, Y. P., Shih, J. Y., Roffler, S. R., Wu, C. W., Yang, P. C. Detection and quantitation of circulating cancer cells in the peripheral blood of lung cancer patients. Cancer Research 58, 2761-2765 (1998). DOI
50. Panteleakou, Z., Lembessis, P., Sourla, A., Pissimissis, N., Polyzos, A., Deliveliotis, C., Koutsilieris, M. Detection of circulating tumor cells in prostate cancer patients: methodological pitfalls and clinical relevance. Mol Med 15, 101-114 (2009). DOI: 10.2119/molmed.2008.00116
51. Kutun, S., Celik, A., Cem Kockar, M., Erkorkmaz, U., Eroglu, A., Cetin, A., Erkosar, B., Yakicier, C. Expression of CK-19 and CEA mRNA in peripheral blood of gastric cancer patients. Experimental Oncology 32, 263-268 (2010). DOI
52. Lankiewicz, S., Rother, E., Zimmermann, S., Hollmann, C., Korangy, F., Greten, T. F. Tumour-associated transcripts and EGFR deletion variants in colorectal cancer in primary tumour, metastases and circulating tumour cells. Cellular Oncology: the Official Journal of the International Society for Cellular Oncology 30, 463-471 (2008). DOI
53. Becker, S., Becker-Pergola, G., Fehm, T., Wallwiener, D., Solomayer, E. F. Time is an important factor when processing samples for the detection of disseminated tumor cells in blood/bone marrow by reverse transcription-PCR. Clinical Chemistry 50, 785-786 (2004). DOI: 10.1373/clinchem.2003.025510
54. Sastre, J., Maestro, M. L., Puente, J., Veganzones, S., Alfonso, R., Rafael, S., Garcia-Saenz, J. A., Vidaurreta, M., Martin, M., Arroyo, M., Sanz-Casla, M. T., Diaz-Rubio, E. Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables. Annals of Oncology: Official Journal of the European Society for Medical Oncology/ESMO 19, 935-938 (2008). DOI: 10.1093/annonc/mdm583
55. de Bono, J. S., Scher, H. I., Montgomery, R. B., Parker, C., Miller, M. C., Tissing, H., Doyle, G. V., Terstappen, L. W., Pienta, K. J., Raghavan, D. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clinical cancer Research: an Official Journal of the American Association for Cancer Research 14, 6302-6309 (2008). DOI: 10.1158/1078-0432.CCR-08-0872
56. Riethdorf, S., Fritsche, H., Muller, V., Rau, T., Schindlbeck, C., Rack, B., Janni, W., Coith, C., Beck, K., Janicke, F., Jackson, S., Gornet, T., Cristofanilli, M., Pantel, K. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clinical Cancer Research: an Official Journal of the American Association for Cancer Research 13, 920-928 (2007). DOI: 10.1158/1078-0432.CCR-06-1695
57. Farace, F., Massard, C., Vimond, N., Drusch, F., Jacques, N., Billiot, F., Laplanche, A., Chauchereau, A., Lacroix, L., Planchard, D., Le Moulec, S., Andre, F., Fizazi, K., Soria, J. C., Vielh, P. A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas. British Journal of Cancer 105, 847-853 (2011). DOI: 10.1038/bjc.2011.294
58. Medina, A., Brown, E., Carr, N., Ghahary, A. Circulating monocytes have the capacity to be transdifferentiated into keratinocyte-like cells. Wound Repair and Regeneration: Official Publication of the Wound Healing Society [and] the European Tissue Repair Society 17, 268-277 (2009). DOI: 10.1111/j.1524-475X.2009.00457.x
59. Cheng, W. Y., Kandel, J. J., Yamashiro, D. J., Canoll, P., Anastassiou, D. A multi-cancer mesenchymal transition gene expression signature is associated with prolonged time to recurrence in glioblastoma. PloS One 7, e34705 (2012). DOI: 10.1371/journal.pone.0034705
60. Stoyianni, A., Goussia, A., Pentheroudakis, G., Siozopoulou, V., Ioachim, E., Krikelis, D., Golfinopoulos, V., Cervantes, A., Bobos, M., Fotsis, T., Bellou, S., Fountzilas, G., Malamou-Mitsi, V., Pavlidis, N. Immunohistochemical study of the epithelial-mesenchymal transition phenotype in cancer of unknown primary: incidence, correlations and prognostic utility. Anticancer Research 32, 1273-1281 (2012). DOI
61. Sugimoto, H., Ito, M., Hatano, M., Kondo, S., Suzuki, S., Yoshizaki, T. Roles of epithelial-mesenchymal transition in squamous cell carcinoma of the temporal bone. Otology & Neurotology: Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 32, 483-487 (2011). DOI: 10.1097/MAO.0b013e31820d9654
62. Berx, G., Raspe, E., Christofori, G., Thiery, J. P., Sleeman, J. P. Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer. Clinical & Experimental Metastasis 24, 587-597 (2007). DOI: 10.1007/s10585-007-9114-6
63. Kalluri, R., Weinberg, R. A. The basics of epithelial-mesenchymal transition. The Journal of Clinical Investigation 119, 1420-1428 (2009). DOI: 10.1172/JCI39104
64. Thiery, J. P. Epithelial-mesenchymal transitions in tumour progression. Nature Reviews. Cancer 2, 442-454 (2002). DOI: 10.1038/nrc822
65. Mani, S. A., Guo, W., Liao, M. J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., Campbell, L. L., Polyak, K., Brisken, C., Yang, J., Weinberg, R. A. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715 (2008). DOI: 10.1016/j.cell.2008.03.027
66. Polyak, K., Weinberg, R. A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nature Reviews. Cancer 9, 265-273 (2009). DOI: 10.1038/nrc2620
67. Thiery, J. P., Acloque, H., Huang, R. Y., Nieto, M. A. Epithelial-mesenchymal transitions in development and disease. Cell 139, 871-890 (2009). DOI: 10.1016/j.cell.2009.11.007
68. Lecharpentier, A., Vielh, P., Perez-Moreno, P., Planchard, D., Soria, J. C., Farace, F. Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer. British Journal of Cancer 105, 1338-1341 (2011). DOI: 10.1038/bjc.2011.405
69. Ozaki, K., Yamagami, T., Nomura, K., Narama, I. Prognostic significance of surgical margin, Ki-67 and cyclin D1 protein expression in grade II canine cutaneous mast cell tumor. The Journal of Veterinary Medical Science/the Japanese Society of Veterinary Science 69, 1117-1121 (2007). DOI
70. Balic, M., Lin, H., Young, L., Hawes, D., Giuliano, A., McNamara, G., Datar, R. H., Cote, R. J. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 12, 5615-5621 (2006). DOI: 10.1158/1078-0432.CCR-06-0169
71. Allan, A. L., Vantyghem, S. A., Tuck, A. B., Chambers, A. F. Tumor dormancy and cancer stem cells: implications for the biology and treatment of breast cancer metastasis. Breast Disease 26, 87-98 (2006). DOI
72. Hofman, V., Long, E., Ilie, M., Bonnetaud, C., Vignaud, J. M., Flejou, J. F., Lantuejoul, S., Piaton, E., Mourad, N., Butori, C., Selva, E., Marquette, C. H., Poudenx, M., Sibon, S., Kelhef, S., Venissac, N., Jais, J. P., Mouroux, J., Molina, T. J., Vielh, P., Hofman, P. Morphological analysis of circulating tumour cells in patients undergoing surgery for non-small cell lung carcinoma using the isolation by size of epithelial tumour cell (ISET) method. Cytopathology: Official Journal of the British Society for Clinical Cytology 23, 30-38 (2012). DOI: 10.1111/j.1365-2303.2010.00835.x
73. Maheswaran, S., Haber, D. A. Circulating tumor cells: a window into cancer biology and metastasis. Current Opinion in Genetics & Development 20, 96-99 (2010). DOI: 10.1016/j.gde.2009.12.002
74. Lelievre, L., Paterlini-Brechot, P., Camatte, S., Tartour, E., Aggerbeck, M., Vilde, F., Lecuru, F. Effect of laparoscopy versus laparotomy on circulating tumor cells using isolation by size of epithelial tumor cells. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 14, 229-233 (2004). DOI: 10.1111/j.1048-891X.2004.014205.x
75. Nanal, R., Kyle, P., Soothill, P. W. A classification of pregnancy losses after invasive prenatal diagnostic procedures: an approach to allow comparison of units with a different case mix. Prenatal Diagnosis 23, 488-492 (2003). DOI: 10.1002/pd.623
76. Bianchi, D. W. Fetal cells in the maternal circulation: feasibility for prenatal diagnosis. British Journal of Haematology 105, 574-583 (1999). DOI
77. NICE. National Institute for Health and Clinical Excellence: Guidance (2008 Mar).
78. Finning, K. M., Martin, P. G., Soothill, P. W., Avent, N. D. Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion 42, 1079-1085 (2002). DOI
79. Vona, G., Beroud, C., Benachi, A., Quenette, A., Bonnefont, J. P., Romana, S., Dumez, Y., Lacour, B., Paterlini-Brechot, P. Enrichment, immunomorphological, and genetic characterization of fetal cells circulating in maternal blood. The American Journal of Pathology 160, 51-58 (2002). DOI: 10.1016/S0002-9440(10)64348-9
80. Beroud, C., Karliova, M., Bonnefont, J. P., Benachi, A., Munnich, A., Dumez, Y., Lacour, B., Paterlini-Brechot, P. Prenatal diagnosis of spinal muscular atrophy by genetic analysis of circulating fetal cells. Lancet 361, 1013-1014 (2003). DOI
81. Saker, A., Benachi, A., Bonnefont, J. P., Munnich, A., Dumez, Y., Lacour, B., Paterlini-Brechot, P. Genetic characterisation of circulating fetal cells allows non-invasive prenatal diagnosis of cystic fibrosis. Prenatal Diagnosis 26, 906-916 (2006). DOI: 10.1002/pd.1524
82. Funaki, S., Sawabata, N., Nakagiri, T., Shintani, Y., Inoue, M., Kadota, Y., Minami, M., Okumura, M. Novel approach for detection of isolated tumor cells in pulmonary vein using negative selection method: morphological classification and clinical implications. European Journal of Cardio-thoracic Surgery: Official Journal of the European Association for Cardio-thoracic Surgery 40, 322-327 (2011). DOI: 10.1016/j.ejcts.2010.11.029
83. Mehes, G., Witt, A., Kubista, E., Ambros, P. F. Circulating breast cancer cells are frequently apoptotic. The American Journal of Pathology 159, 17-20 (2001). DOI: 10.1016/S0002-9440(10)61667-7